Skip to Main content Skip to Navigation
Journal articles

Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?

Etienne Garin 1, 2, * Xavier Pallard 2, 1 Julien Edeline 1, 3
* Corresponding author
1 Foie, métabolismes et cancer
2 CRLCC - CRLCC Eugène Marquis
3 Département d'oncologie médicale [Rennes]
Abstract : Correspondence. Dear Editors: It is with great interest that we read the publication written by Salem et al1: “Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.”...
Document type :
Journal articles
Complete list of metadata
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01520290
Contributor : Laurent Jonchère <>
Submitted on : Wednesday, May 10, 2017 - 11:39:27 AM
Last modification on : Monday, July 5, 2021 - 12:17:01 PM

Identifiers

Collections

UNIV-RENNES1 | NUMECAN | MARQUIS | FNCLCC | BIOSIT | UR1-UFR-SVE | NUMECAN-TGTC | UNIV-RENNES

Citation

Etienne Garin, Xavier Pallard, Julien Edeline. Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?. Gastroenterology, WB Saunders, 2017, 152 (6), pp.1624-1625. ⟨10.1053/j.gastro.2017.01.061⟩. ⟨hal-01520290⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

182